Patents by Inventor Pengpeng XU

Pengpeng XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250145417
    Abstract: A control method for a conveyor device, which is applicable to a control system comprising a control terminal and one or more control nodes, each of the control nodes is in communication connection with the control terminal. The method includes controlling, by the control node that receives an operation signal, a movable device associated with the control node to reach a conveyor device to be controlled, in response to the operation signal sent by a control terminal; and determining whether to control the conveyor device to be controlled according to the indication of the operation signal, based on sensed data from a sensing device regarding the condition of an object to be conveyed on the conveyor device to be controlled.
    Type: Application
    Filed: October 28, 2024
    Publication date: May 8, 2025
    Inventors: Lifei Cheng, Pengpeng Xu, Zhaoxia Hu
  • Patent number: 12194054
    Abstract: The present application provides an application of Chidamide in combination with R-CHOP in preparing a drug used for treating B-cell lymphoma, and also provides a drug comprising Chidamide and R-CHOP. Chidamide in combination with R-CHOP has a synergistic therapeutic effect on B-cell lymphoma.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: January 14, 2025
    Assignees: SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD., RUI JIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
    Inventors: Xianping Lu, Weili Zhao, Xin Fu, Pengpeng Xu, Ting Liu
  • Publication number: 20230212384
    Abstract: A high-temperature-resistant insulating polymer composite is provided, including the following components in parts by mass: 3-12 parts of cyanate ester resin, 3-20 parts of epoxy resin, 5-15 parts of an inorganic filler, 0.1-2 parts of an epoxy resin curing agent, 0.0001-0.005 parts of a curing accelerant, and 0.1-2 parts of a dispersant. A glass transition temperature of the cured high-temperature-resistant insulating polymer composite is higher than 120° C.
    Type: Application
    Filed: September 10, 2019
    Publication date: July 6, 2023
    Applicant: SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
    Inventors: Suibin LUO, Panpan RUAN, Pengpeng XU, Rong SUN, Shuhui YU
  • Publication number: 20220411667
    Abstract: The insulation adhesive film material is composed of a three-layer structure, its insulation polymer composite is supported by a thin film material, and a surface of the insulation polymer composite is covered with a layer of protective film. A release force of a support film is 25-60 ?N/mm, and a release force of the protective film is 2-60 ?N/mm. A thickness of the insulation polymer composite is 1-300 ?m. The insulation adhesive film material is prepared as follows: after a high molecular polymer, an inorganic filler, a high molecular polymer curing agent, a molding auxiliary agent, and a solvent are mixed, dispersion technologies such as ball milling, sand milling, ultrasound are conducted to prepare an electronic paste of the insulation polymer composite, and the electronic paste is then applied to a surface of a support film material, and bonded with the protective film to form the insulation adhesive film material.
    Type: Application
    Filed: October 10, 2019
    Publication date: December 29, 2022
    Applicant: SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
    Inventors: Suibin LUO, Pengpeng XU, Panpan RUAN, Shuhui YU, Tao ZHAO, Rong SUN
  • Publication number: 20220016147
    Abstract: The present application provides an application of Chidamide in combination with R-CHOP in preparing a drug used for treating B-cell lymphoma, and also provides a drug comprising Chidamide and R-CHOP. Chidamide in combination with R-CHOP has a synergistic therapeutic effect on B-cell lymphoma.
    Type: Application
    Filed: November 18, 2019
    Publication date: January 20, 2022
    Inventors: Weili ZHAO, Ting LIU, Xianping LU, Pengpeng XU, Xin FU